Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,291 papers from all fields of science
Search
Sign In
Create Free Account
Superficial Bladder Carcinoma
Known as:
Superficial Bladder Cancer
, Superficial Urinary Bladder Cancer
, Superficial Urinary Bladder Carcinoma
A term used by urologists to describe an infiltrating carcinoma of the bladder that has not invaded into the muscularis propria of the bladder wall…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Epithelial Cells
Epithelium
Hematuria
Malignant Epithelial Cell
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Promoter Hypermethylation in Tumour Suppressor Genes Shows Association with Stage, Grade and Invasiveness of Bladder Cancer
S. Jarmalaitė
,
F. Jankevicius
,
K. Kurgonaite
,
K. Suziedelis
,
P. Mutanen
,
K. Husgafvel‐Pursiainen
Oncology
2008
Corpus ID: 32871875
Aims: Superficial bladder cancer is a highly recurrent disease, with progression to muscle invasiveness occurring in 15–30% of…
Expand
Highly Cited
2003
Highly Cited
2003
Ki‐67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification
L. Santos
,
T. Amaro
,
+6 authors
C. Lopes
International Journal of Cancer
2003
Corpus ID: 25115259
Approximately 80% of bladder tumors are urothelial superficial papillary carcinomas (USPC). Despite a generally good prognosis…
Expand
Highly Cited
2001
Highly Cited
2001
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
A. Jones
,
C. Fujiyama
,
+5 authors
A. Harris
Clinical Cancer Research
2001
Corpus ID: 20486733
Hypoxia is an important regulator of vascular endothelial growth factor (VEGF) expression, and VEGF is associated with poor…
Expand
Highly Cited
2001
Highly Cited
2001
T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer.
F. Saint
,
J. Patard
,
+6 authors
D. Chopin
Journal of Urology
2001
Corpus ID: 25445176
Highly Cited
2000
Highly Cited
2000
Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer.
M. Brake
,
H. Loertzer
,
R. Horsch
,
H. Keller
Urology
2000
Corpus ID: 22823041
Highly Cited
1996
Highly Cited
1996
Initial evaluation of the bladder tumor antigen test in superficial bladder cancer.
M. D’Hallewin
,
L. Baert
Journal of Urology
1996
Corpus ID: 9020310
Highly Cited
1996
Highly Cited
1996
Prevalence and Clinical Significance of Her-2/neu, p53 and Rb Expression in Primary Superficial Bladder Cancer
B. Têtu
,
Y. Fradet
,
P. Allard
,
C. Veilleux
,
N. Roberge
,
P. Bernard
1996
Corpus ID: 72889120
Highly Cited
1994
Highly Cited
1994
Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer.
L. Kiemeney
,
J. Witjes
,
R. P. Heijbroek
,
F. Debruyne
,
A. Verbeek
European Journal of Cancer
1994
Corpus ID: 34985011
Highly Cited
1989
Highly Cited
1989
Long-term results of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer.
M. Sarosdy
,
D. Lamm
Journal of Urology
1989
Corpus ID: 32617781
Highly Cited
1981
Highly Cited
1981
The effect of mitomycin C on superficial bladder cancer.
M. Soloway
,
M. Soloway
,
+7 authors
Pamela Finebaum
Journal of Urology
1981
Corpus ID: 5713380
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE